The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease

By sjmartinez • January 19, 2025

Packard RRS. The clinical promise of ¹⁸F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease. Nat Cardiovasc Res. 2025 Jan;4(1):1-4. doi: 10.1038/s44161-024-00587-w. PMID: 39825085.

Tags: Cardiology/Epi, Publications

Predictive Value of Coronary Artery Calcium Score From Nongated Chest CT Scans Compared With Gated Scans and Incidence of Cardiovascular Events

Verghese D, Trujillo R, Abraham D, McClelland RL, Kinninger A, Manubolu S, Aldana J, Cubeddu RJ, Drachman D, Inglessis-Azuaje I, Wang DD, Fahed A, Brumback[...]

Intestinal lipase inhibition uncouples diet-induced obesity from MASH by remodeling the hepatic lipidome in mice

Chan AP, Czernuszewicz TJ, Lai RW, Jarrett KE, Lau A, Warshan A, Cheng AS, Steel ME, Schmidt HM, Larios J, Little I, Rubert GE, Brearley-Sholto[...]

Combined Pharmacologic and Nutritional Modulation of High-Fat Diet-Associated Tumor-Supportive Features in Prostate Cancer Models

Wu K, Hao Q, Yang J, Elshimali Y, Magyar CE, Henning SM, Andalibi A, Wang P. Combined Pharmacologic and Nutritional Modulation of High-Fat Diet-Associated Tumor-Supportive[...]